Sapatnekar, Aniruddha. 2025. “Conventional Synthetic Disease-Modifying Drugs Remain the Mainstay of Therapy for Rheumatoid Arthritis in India”. Journal of the Diabetic Association of India 1 (1). https://journals.onemd.in/index.php/jdai/article/view/59.